BioCryst Pharmaceuticals, Inc

(NASDAQ:BCRX)

Latest On BioCryst Pharmaceuticals, Inc (BCRX):

Date/Time Type Description Signal Details
2023-05-31 17:21 ESTNewsBioCryst Pharmaceuticals: An Updated ViewN/A
2023-05-03 21:24 ESTNewsBioCryst Pharmaceuticals, Inc. 2023 Q1 - Results - Earnings Call PresentationN/A
2023-05-03 21:24 ESTNewsBioCryst Pharmaceuticals, Inc. (BCRX) Q1 2023 Earnings Call TranscriptN/A
2023-05-03 21:24 ESTNewsBioCryst gains 14% most since February after Q1 2023 resultsN/A
2023-05-03 08:06 ESTNewsBioCryst Pharmaceuticals GAAP EPS of -$0.28 beats by $0.03, revenue of $68.78M misses by $2.66MN/A
2023-04-18 20:53 ESTNewsBioCryst secures five-year credit facilityN/A
2023-04-12 14:45 ESTNewsThe Big Short: 5 Stocks At Risk With High Short InterestN/A
2023-03-17 06:01 ESTNewsBioCryst's Commercialization Of Orladeyo: Risks Materializing, A Shorting OpportunityN/A
2023-03-08 22:50 ESTNewsBioCryst: Good Candidate For Buyout, But Not For Anything ElseN/A
2023-03-08 22:50 ESTNewsBioCryst wins Canadian nod for Orladeyo reimbursementN/A
2023-03-02 13:37 ESTNewsBioCryst Pharmaceuticals (BCRX) Presents At J.P. MORGAN HEALTHCARE CONFERENCEN/A
2023-02-22 23:25 ESTNewsBioCryst adds 13% to rebound as Needham upgrades; says selloff overdoneN/A
2023-02-22 10:26 ESTNewsBioCryst Is Not Currently Uncovering The Full Value Of ORLADEYON/A
2023-02-21 21:57 ESTNewsBioCryst at nine-month low as Q4 bottom-line disappointsN/A
2023-02-21 21:57 ESTNewsBioCryst Pharmaceuticals, Inc. (BCRX) Q4 2022 Earnings Call TranscriptN/A
2023-02-21 21:57 ESTNewsBioCryst Pharmaceuticals, Inc. 2022 Q4 - Results - Earnings Call PresentationN/A
2023-02-21 08:13 ESTNewsBioCryst Pharmaceuticals Non-GAAP EPS of -$0.38 misses by $0.18, revenue of $79.5M beats by $5.32MN/A
2023-02-20 19:27 ESTNewsBioCryst Pharmaceuticals Q4 2022 Earnings PreviewN/A
2023-02-04 07:22 ESTNewsBioCryst Pharmaceuticals: An Overview Of Orladeyo For Hereditary AngioedemaN/A
2023-01-23 12:51 ESTNewsBioCryst teams up with Swixx to sell Orladeyo in Central, Eastern EuropeN/A
2023-01-09 13:46 ESTNewsBioCryst drops as sales for hereditary angioedema therapy lag forecastsN/A
2022-12-21 02:03 ESTNewsBioCryst Pharmaceuticals: More Aggressive Growth For OrladeyoN/A
2022-12-16 00:24 ESTNewsBioCryst drops on plans to discontinue oral Factor D inhibitorN/A
2022-12-16 00:22 ESTNewsBioCryst strategic interest likely to rise after oral Factor D inhibitor decision - CowenN/A
2022-12-06 15:56 ESTNewsBad flu season turned even worse around Thanksgiving - CDCN/A
2022-11-15 15:48 ESTNewsBioCryst Pharmaceuticals (BCRX) Investor Presentation -SlideshowN/A
2022-11-04 16:23 ESTNewsFewer Americans have received the flu shot compared to same time last year - CDCN/A
2022-11-02 13:59 ESTNewsBioCryst rebounds as Evercore ISI upgrades after earnings day selloffN/A
2022-11-01 22:53 ESTNewsBioCryst Pharmaceuticals reports Q3 earnings beat; updates FY22 guidanceN/A
2022-11-01 22:53 ESTNewsBioCryst Pharmaceuticals, Inc. 2022 Q3 - Results - Earnings Call PresentationN/A
2022-11-01 22:53 ESTNewsBioCryst Pharmaceuticals, Inc. (BCRX) Q3 2022 Earnings Call TranscriptN/A
2022-11-01 22:52 ESTNewsBioCryst falls 11% despite Q3 beat (update)N/A
2022-10-28 13:05 ESTNewsFlu season off to a strong and early start, CDC data findsN/A
2022-10-11 12:49 ESTNewsBioCryst Pharmaceuticals: Working To Increase Market Presence Of OrladeyoN/A
2022-09-14 19:02 ESTNewsBioCryst Pharmaceuticals promotes Sheridan to development chiefN/A
2022-08-31 10:00 ESTNewsBioCryst wins FDA’s Orphan Drug status for bone disorder therapyN/A
2022-08-26 17:59 ESTNewsBioCryst's BCX9930 for rare kidney disorder shows promise in early-stage studyN/A
2022-08-25 09:20 ESTNewsBioCryst to supply 10K doses of influenza drug Rapivab to US for ~$7MN/A
2022-08-18 07:38 ESTNewsBioCryst Orladeyo gets approval in Saudi Arabia to prevent hereditary angioedema attacksN/A
2022-08-04 23:49 ESTNewsBioCryst Pharmaceuticals, Inc. 2022 Q2 - Results - Earnings Call PresentationN/A
2022-08-04 23:49 ESTNewsBioCryst adds 16% as FDA lifts clinical hold on kidney disease programN/A
2022-08-04 23:48 ESTNewsBioCryst Pharmaceuticals, Inc. (BCRX) CEO Jon Stonehouse on Q2 Results - Earnings Call TranscriptN/A
2022-08-04 08:14 ESTNewsBioCryst Pharmaceuticals GAAP EPS of -$0.32 beats by $0.03, revenue of $65.53M beats by $1.7MN/A
2022-08-03 17:46 ESTNewsBioCryst Pharmaceuticals Q2 2022 Earnings PreviewN/A
2022-07-26 00:41 ESTNewsBioCryst Pharmaceuticals: Waiting For ClarityN/A
2022-06-24 22:18 ESTNewsBioCryst: A Prudent DiversificationN/A
2022-06-19 14:18 ESTNewsBioCryst Pharmaceuticals (BCRX) Investor Presentation - SlideshowN/A
2022-06-10 13:01 ESTNewsBioCryst collaborates with Pint Pharma to sell Orladeyo in Latin AmericaN/A
2022-06-08 15:55 ESTNewsBioCryst nabs FDA’s Fast Track status for candidate targeting rare bone forming disorderN/A
2022-06-08 00:50 ESTNewsBioCryst Orladeyo gets approval in Switzerland to prevent hereditary angioedema attacksN/A

About BioCryst Pharmaceuticals, Inc (BCRX):

BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers oral and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor, for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and Mundesine, an oral purine nucleoside phosphorylase inhibitor for peripheral T-cell lymphoma. It is also developing ORLADEYO, an oral serine protease inhibitor to treat hereditary angioedema; BCX9930, an oral factor D inhibitor, which is in Phase I clinical trials for mediated diseases; BCX9250, an oral activin receptor-like kinase-2 inhibitors that is in Phase I clinical trials to treat fibrodysplasia ossificans progressiva; and Galidesivir, a RNA dependent-RNA polymerase inhibitor, which is in Phase I clinical trials to treat various RNA viruses, including Marburg, Yellow Fever, Ebola, and Zika. The company has collaborations and in-license relationships with U.S. Department of Health and Human Services; National Institute of Allergy and Infectious Diseases; Torii Pharmaceutical Co., Ltd.; Seqirus UK Limited; Shionogi & Co., Ltd.; Green Cross Corporation; Mundipharma International Holdings Limited; and The University of Alabama at Birmingham, as well as Albert Einstein College of Medicine of Yeshiva University and Industrial Research, Ltd. BioCryst Pharmaceuticals, Inc. was founded in 1986 and is headquartered in Durham, North Carolina.

BCRX Quotes by TradingView

See Advanced Chart

General

  • Name BioCryst Pharmaceuticals, Inc
  • Symbol BCRX
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 246
  • Fiscal Year EndDecember
  • IPO Date1994-03-03
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.biocryst.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 31.41
  • Price/Book (Most Recent Quarter) 56.59
  • Enterprise Value Revenue 103.35
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$1.05
  • Next Year EPS Estimate -$0.73
  • Next Quarter EPS Estimate -$0.28
  • Operating Margin -981%
  • Return on Assets -43%
  • Return on Equity -1925%
  • Revenue 17.81 million
  • Earnings Per Share -$1.15
  • Revenue Per Share $0.11
  • Gross Profit -106828000
  • Quarterly Earnings Growth -89.9%
View More

Highlights

  • Market Capitalization 2.25 billion
  • EBITDA -106253000
  • PE Ratio -12.32
  • PEG Ratio -0.28
  • Analyst Target Price $13.78
  • Book Value Per Share $0.19
View More

Share Statistics

  • Shares Outstanding 177.52 million
  • Shares Float 162.86 million
  • % Held by Insiders 85%
  • % Held by Institutions 73.95%
  • Shares Short 28.92 million
  • Shares Short Prior Month 28.86 million
  • Short Ratio 3.27
  • Short % of Float 18%
  • Short % of Shares Outstanding 16%
View More

Technicals

  • Beta 2.82
  • 52 Week High $13.93
  • 52 Week Low $1.78
  • 50 Day Moving Average 11.07
  • 200 Day Moving Average 6.8
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

BioCryst Pharmaceuticals, Inc (BCRX) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

BioCryst Pharmaceuticals, Inc (BCRX) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-02-25$N/A-$0.34-$0.24-42.56%
2020-09-302020-11-05$N/A-$0.26-$0.26-1.13%
2020-06-302020-08-06$N/A-$0.24-$0.254.53%
2020-03-312020-05-06$N/A-$0.24-$0.240.62%
2019-12-312020-03-05$39.73 million-$0.02-$0.2792.51%
2019-09-302019-11-06$1.78 million-$0.34-$0.31-8.11%
2019-06-302019-08-06$1.45 million-$0.34-$0.32-7.12%
2019-03-312019-05-08$5.89 million-$0.28-$0.28-1.82%
2018-12-312019-03-04$2.73 million-$0.25-$0.24-2.75%
2018-09-302018-11-06$1.45 million-$0.28-$0.26-7.94%
2018-06-302018-08-07$12.49 million-$0.19-$0.2421.26%
2018-03-312018-05-08$3.98 million-$0.26-$0.19-35.06%
2017-12-312018-02-27$3.89 million-$0.20-$0.16-26.5%
2017-09-302017-11-07$8.76 million-$0.18-$0.182.39%
2017-06-302017-08-07$3.1 million-$0.21-$0.19-10.53%
2017-03-312017-05-04$9.44 million-$0.19-$0.19-2.15%
2016-12-312017-02-27$8.98 million-$0.06-$0.2474.82%
2016-09-302016-11-07$7.76 million-$0.16-$0.2637.84%
2016-06-302016-08-04$4.79 million-$0.22-$0.2615.25%
2016-03-312016-05-05$4.82 million-$0.31-$0.23-34.32%
2015-12-312016-02-23$4.6 million-$0.25-$0.250.68%
2015-09-302015-11-05$10.99 million-$0.20-$0.200%
2015-06-302015-08-07$25.84 million$0.06-$0.22127.27%
2015-03-312015-05-08$6.83 million-$0.21-$0.2516%
2014-12-312015-02-18$5.45 million-$0.16-$0.2123.81%
2014-09-302014-11-06$3.24 million-$0.12-$0.2040%
2014-06-302014-08-05$1.47 million-$0.23-$0.19-21.05%
2014-03-312014-05-08$3.46 million-$0.17-$0.170%
2013-12-312014-02-26$10.57 million-$0.09-$0.090%
2013-09-302013-11-05$2.39 million-$0.14-$0.11-27.27%
2013-06-302013-08-08$821000-$0.23-$0.13-76.92%
2013-03-312013-05-07$3.55 million-$0.09-$0.1540%
2012-12-312013-02-19$4.1 million-$0.18-$0.16-12.5%
2012-09-302012-11-08$5.76 million-$0.19-$0.2524%
2012-06-302012-08-02$4.21 million-$0.25-$0.263.85%
2012-03-312012-05-07$12.22 million-$0.13-$0.2650%
2011-12-312012-02-16$5.22 million-$0.29-$0.28-3.57%
2011-09-302011-11-02$5.25 million-$0.32-$0.26-23.08%
2011-06-302011-08-04$3.74 million-$0.36-$0.25-44%
2011-03-312011-05-04$5.44 million-$0.29-$0.20-45%
2010-12-312011-02-10$16.69 million-$0.20-$0.214.76%
2010-09-302010-10-28$12 million-$0.24-$0.17-41.18%
2010-06-302010-08-05$7.62 million-$0.23-$0.22-4.55%
2010-03-312010-04-28$26.07 million-$0.06-$0.1662.5%
2009-12-312010-02-04$54.9 million$0.35$0.09288.89%
2009-09-302009-10-29$10.55 million-$0.28-$0.22-27.27%
2009-06-302009-07-30$4.79 million-$0.23-$0.258%
2009-03-312009-05-08$4.36 million-$0.24-$0.2814.29%
2008-12-312009-02-06$34.24 million$0.26-$0.22218.18%
2008-09-302008-10-31$8.89 million-$0.24-$0.240%
2008-06-302008-08-07$2.66 million-$0.33-$0.20-65%
2008-03-312008-05-08$10.77 million-$0.34-$0.18-88.89%
2007-12-312008-03-04$28.17 million-$0.06-$0.3984.62%
2007-09-302007-11-08$20.46 million-$0.32-$0.28-14.29%
2007-06-302007-08-09$13.44 million-$0.24-$0.3327.27%
2007-03-312007-05-09$9.16 million-$0.30-$0.27-11.11%
2006-12-312007-02-07$2.09 million-$0.34-$0.5032%
2006-09-302006-11-08$1.79 million-$0.53-$0.41-29.27%
2006-06-302006-08-09$1.56 million-$0.35-$0.29-20.69%
2006-03-312006-04-27$771000-$0.27-$0.24-12.5%
2005-12-312006-02-08$21000-$0.27-$0.296.9%
2005-09-302005-10-26$32000-$0.29-$0.24-20.83%
2005-06-302005-08-03$58000-$0.22-$0.2512%
2005-03-312005-04-21$41000-$0.24-$0.240%
2004-12-312005-02-02$178000-$0.24-$0.267.69%
2004-09-302004-10-20$116000-$0.24-$0.240%
2004-06-302004-07-21$43000-$0.23-$0.2817.86%
2004-03-312004-04-21$N/A-$0.28-$0.22-27.27%
2003-12-312004-02-04$654000-$0.18-$0.2010%
2003-09-302003-10-20$N/A-$0.19
2003-06-302003-07-30$N/A-$0.18
2003-03-312003-03-31$N/A-$0.16
2002-12-312002-12-31$N/A-$0.16
2002-09-302002-09-30$N/A-$0.19
2002-06-302002-06-30$N/A-$0.29
2002-03-312002-03-31$N/A-$0.32
2001-12-312002-01-30$4.34 million-$0.28-$0.14-100%
2001-09-302001-10-24$3.4 million$0.02-$0.13115.38%
2001-06-302001-07-25$3.64 million-$0.08-$0.1233.33%
2001-03-312001-04-25$703000-$0.08-$0.1127.27%
2000-12-312001-02-01$803000-$0.11-$0.128.33%
2000-09-302000-10-25$763000-$0.09-$0.1118.18%
2000-06-302000-07-26$1.19 million-$0.11-$0.128.33%
2000-03-312000-04-26$564000$0.10-$0.04350%
1999-12-312000-02-02-$0.03-$0.01-200%
1999-09-301999-10-21-$0.15-$0.1816.67%
1999-06-301999-07-21-$0.02-$0.0875%
1999-03-311999-03-31-$0.16
1998-12-311999-01-27-$0.10-$0.2458.33%
1998-09-301998-10-28$0.19$0.185.56%
1998-06-301998-07-22-$0.21-$0.2516%
1998-03-311998-03-31-$0.22
1997-12-311998-02-03-$0.21-$0.238.7%
1997-03-311997-04-28-$0.23-$0.12-91.67%
1996-12-311997-02-10-$0.15-$0.2128.57%
1996-09-301996-10-29-$0.23-$0.2817.86%
1996-06-301996-07-25-$0.11$0.05-320%
1996-03-311996-04-24-$0.20-$0.2623.08%
1995-12-311996-01-29-$0.23-$0.2611.54%
1995-09-301995-10-17-$0.20-$0.2313.04%
1995-06-301995-07-25-$0.18-$0.3345.45%
1995-03-311995-04-28-$0.37-$0.31-19.35%
1994-12-311995-01-31-$0.24-$0.267.69%
1994-09-301994-10-26-$0.22-$0.3129.03%
1994-06-301994-08-02-$0.25-$0.3324.24%

BioCryst Pharmaceuticals, Inc (BCRX) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

BioCryst Pharmaceuticals, Inc (BCRX) Chart:

BioCryst Pharmaceuticals, Inc (BCRX) News:

Below you will find a list of latest news for BioCryst Pharmaceuticals, Inc (BCRX) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

BioCryst Pharmaceuticals, Inc (BCRX) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2026-07-177.56.5CALL 10.03TRUE00
2026-07-1712.50.85CALL2 180.25FALSE00
2026-07-17100.15PUT 1020TRUE00
2026-05-1518.3CALL1 0565.11TRUE8.30
2026-05-1527.3CALL1 0379.92TRUE7.30
2026-05-1530CALL0 0245.14TRUE00
2026-05-1545.52CALL0 8185.32TRUE00
2026-05-1550CALL0 1152.44TRUE00
2026-05-1560CALL0 110TRUE00
2026-05-1573.1CALL0 658.4TRUE00
2026-05-1581.63CALL0 1151.96TRUE00
2026-05-1590.7CALL138 21162.04TRUE-0.25-0.26
2026-05-15100.4CALL283 245472.72FALSE-0.2-0.33
2026-05-15110.25CALL35 163982.47FALSE0.050.25
2026-05-15120.16CALL45 113589.74FALSE-0.04-0.2
2026-05-15130.12CALL2 898.92FALSE00
2026-05-15140.05CALL12 1593.78FALSE0.050
2026-05-15150.05CALL1 0105.47FALSE0.050
2026-05-15160.04CALL1 0111.67FALSE0.040
2026-05-15170CALL0 0182.28FALSE00
2026-05-1510.03PUT1 0436.31FALSE0.030
2026-05-1520.03PUT1 0298.18FALSE0.030
2026-05-1530.25PUT2 0354.82FALSE0.250
2026-05-1540.04PUT3 2177.66FALSE0.040
2026-05-1550.3PUT3 0123.86FALSE0.30
2026-05-1560.06PUT1 20108.51FALSE0.060
2026-05-1570.17PUT0 31103.45FALSE00
2026-05-1580.13PUT8 411459.09FALSE-0.05-0.28
2026-05-1590.5PUT362 66863.23FALSE0.090.22
2026-05-15100.95PUT0 2962.84TRUE00
2026-05-15110PUT0 1293.82TRUE00
2026-05-15120PUT0 00TRUE00
2026-05-15130PUT0 00TRUE00
2026-05-15140PUT0 00TRUE00
2026-05-15150PUT0 00TRUE00
2026-05-15160PUT0 00TRUE00
2026-05-15170PUT0 00TRUE00
2026-06-1810CALL0 1316.91TRUE00
2026-06-1820CALL0 0211.29TRUE00
2026-06-1830CALL0 0179.56TRUE00
2026-06-1845.54CALL0 5135.56TRUE00
2026-06-1850CALL0 82135.01TRUE00
2026-06-1863.7CALL0 12116TRUE00
2026-06-1870CALL0 93495.72TRUE00
2026-06-1881.62CALL50 100963.13TRUE-0.31-0.16
2026-06-1890.99CALL2 59659.48TRUE-0.41-0.29
2026-06-18100.65CALL27 898864.09FALSE-0.25-0.28
2026-06-18110.45CALL77 146769.25FALSE-0.1-0.18
2026-06-18120.3CALL9 181071.84FALSE-0.11-0.27
2026-06-18130.25CALL0 74384.15FALSE00
2026-06-18140.25CALL94 25789.68FALSE0.250
2026-06-18150.1CALL0 66282.71FALSE00
2026-06-18160CALL0 190.46FALSE00
2026-06-18170CALL0 0108.82FALSE00
2026-06-18180CALL0 099.4FALSE00
2026-06-1810PUT0 00FALSE00
2026-06-1820PUT0 0387.45FALSE00
2026-06-1830PUT0 0286.8FALSE00
2026-06-1840PUT0 0221.98FALSE00
2026-06-1850PUT0 0158.89FALSE00
2026-06-1860PUT0 78134.8FALSE00
2026-06-1870PUT0 522101.33FALSE00
2026-06-1880.35PUT0 4555.71FALSE00
2026-06-1890.8PUT12 62262.94FALSE0.80
2026-06-18101.3PUT40 1856.6TRUE1.30
2026-06-18110PUT0 10136TRUE00
2026-06-18122.72PUT0 60TRUE00
2026-06-18133.71PUT0 70TRUE00
2026-06-18140PUT0 00TRUE00
2026-06-18150PUT0 00TRUE00
2026-06-18160PUT0 00TRUE00
2026-06-18170PUT0 00TRUE00
2026-06-18180PUT0 00TRUE00
2026-09-1810CALL0 0191.93TRUE00
2026-09-1820CALL0 0163.79TRUE00
2026-09-1830CALL0 1156.64TRUE00
2026-09-1845.66CALL0 11184.2TRUE00
2026-09-1850CALL0 096.52TRUE00
2026-09-1860CALL0 088.9TRUE00
2026-09-1873CALL5 109678.71TRUE30
2026-09-1880CALL0 20265.66TRUE00
2026-09-1890CALL0 45368.85TRUE00
2026-09-18101.25CALL504 49764.23FALSE-0.19-0.13
2026-09-18110CALL0 2956.93FALSE00
2026-09-18120.89CALL0 11956.82FALSE00
2026-09-18130CALL0 865.26FALSE00
2026-09-18140CALL0 8963.04FALSE00
2026-09-18150.22CALL0 362.86FALSE00
2026-09-18160CALL0 074.86FALSE00
2026-09-18170CALL0 073.15FALSE00
2026-09-18180CALL0 077.66FALSE00
2026-09-1810PUT0 0344.59FALSE00
2026-09-1820PUT0 0223.05FALSE00
2026-09-1830PUT0 0165.85FALSE00
2026-09-1840PUT0 0128.42FALSE00
2026-09-1850PUT0 3100.37FALSE00
2026-09-1860PUT0 23101.66FALSE00
2026-09-1870.41PUT0 100875.24FALSE00
2026-09-1880PUT0 970.86FALSE00
2026-09-1890PUT0 3762.87FALSE00
2026-09-18100PUT0 155.67TRUE00
2026-09-18110PUT0 3059.3TRUE00
2026-09-18120PUT0 053.3TRUE00
2026-09-18130PUT0 053.13TRUE00
2026-09-18140PUT0 060.33TRUE00
2026-09-18150PUT0 053.63TRUE00
2026-09-18160PUT0 00TRUE00
2026-09-18170PUT0 00TRUE00
2026-09-18180PUT0 00TRUE00
2026-12-1810CALL0 0194.9TRUE00
2026-12-1820CALL0 0125.52TRUE00
2026-12-1830CALL0 0121.09TRUE00
2026-12-1840CALL0 063.74TRUE00
2026-12-1850CALL0 081.37TRUE00
2026-12-1860CALL0 079.59TRUE00
2026-12-1870CALL0 074.28TRUE00
2026-12-1882.7CALL0 163.12TRUE00
2026-12-1890CALL0 069.94TRUE00
2026-12-18100CALL0 057.19FALSE00
2026-12-18110CALL0 054.27FALSE00
2026-12-18120CALL0 068.75FALSE00
2026-12-18130CALL0 056.55FALSE00
2026-12-18140CALL0 059.65FALSE00
2026-12-18150CALL0 061.83FALSE00
2026-12-18160CALL0 065.41FALSE00
2026-12-18170CALL0 068.51FALSE00
2026-12-1810PUT0 0273.56FALSE00
2026-12-1820PUT0 0177.19FALSE00
2026-12-1830PUT0 0131.9FALSE00
2026-12-1840PUT0 0102.29FALSE00
2026-12-1850PUT0 087.57FALSE00
2026-12-1860PUT0 085.42FALSE00
2026-12-1870PUT0 058.01FALSE00
2026-12-1880PUT0 058.09FALSE00
2026-12-1891.45PUT0 257.11FALSE00
2026-12-18100PUT0 060.69TRUE00
2026-12-18110PUT0 055.57TRUE00
2026-12-18120PUT0 053.87TRUE00
2026-12-18130PUT0 053.49TRUE00
2026-12-18140PUT0 044.79TRUE00
2026-12-18150PUT0 053.14TRUE00
2026-12-18160PUT0 00TRUE00
2026-12-18170PUT0 00TRUE00
2027-01-1535.8CALL0 22582.53TRUE00
2027-01-1554.83CALL0 134879.9TRUE00
2027-01-1573.4CALL0 377573.1TRUE00
2027-01-1580CALL0 066.82TRUE00
2027-01-1592.35CALL2 059.09TRUE2.350
2027-01-15101.6CALL115 896957.82FALSE-0.2-0.11
2027-01-15110CALL0 063.82FALSE00
2027-01-15121CALL3 118156.75FALSE-0.15-0.13
2027-01-15130CALL0 057.66FALSE00
2027-01-15150.55CALL77 110958.34FALSE-0.1-0.15
2027-01-15170CALL0 14656.58FALSE00
2027-01-15200CALL0 87053.02FALSE00
2027-01-1530PUT0 15125.13FALSE00
2027-01-1550.27PUT0 14676.09FALSE00
2027-01-1570.63PUT0 20456.33FALSE00
2027-01-1580PUT0 056.25FALSE00
2027-01-1590PUT0 058.64FALSE00
2027-01-15102.11PUT0 95353.09TRUE00
2027-01-15110PUT0 052.31TRUE00
2027-01-15120PUT0 11049.85TRUE00
2027-01-15130PUT0 049.35TRUE00
2027-01-15150PUT0 162.82TRUE00
2027-01-15170PUT0 00TRUE00
2027-01-15200PUT0 00TRUE00
2027-03-1930CALL0 00TRUE00
2027-03-1950CALL0 076.84TRUE00
2027-03-1970CALL0 061.88TRUE00
2027-03-19100CALL0 065.22FALSE00
2027-03-19120CALL0 070.76FALSE00
2027-03-19150CALL0 078.88FALSE00
2027-03-19170CALL0 0118.98FALSE00
2027-03-1930PUT0 0182.62FALSE00
2027-03-1950PUT0 0117.52FALSE00
2027-03-1970PUT0 0124.96FALSE00
2027-03-19100PUT0 057.36TRUE00
2027-03-19120PUT0 052.94TRUE00
2027-03-19150PUT0 050.09TRUE00
2027-03-19170PUT0 055.95TRUE00
2027-04-1630CALL0 090.26TRUE00
2027-04-1650CALL0 073.23TRUE00
2027-04-1670CALL0 082.51TRUE00
2027-04-16100CALL0 064.49FALSE00
2027-04-16120CALL0 046.95FALSE00
2027-04-16150CALL0 054.04FALSE00
2027-04-16170CALL0 057.23FALSE00
2027-04-1630PUT0 0175.76FALSE00
2027-04-1650PUT0 0114.47FALSE00
2027-04-1670PUT0 0120.41FALSE00
2027-04-16100PUT0 057.57TRUE00
2027-04-16120PUT0 053.48TRUE00
2027-04-16150PUT0 050.85TRUE00
2027-04-16170PUT0 00TRUE00
2028-01-2136.94CALL0 283.55TRUE00
2028-01-2150CALL0 084.84TRUE00
2028-01-2170CALL0 077.37TRUE00
2028-01-21102.6CALL21 5156.08FALSE-0.14-0.05
2028-01-21122.3CALL10 061.55FALSE2.30
2028-01-21151.5CALL30 057.39FALSE1.50
2028-01-21170CALL0 065.66FALSE00
2028-01-2130PUT0 0225.63FALSE00
2028-01-2150PUT0 0138.49FALSE00
2028-01-2170PUT0 068.41FALSE00
2028-01-21100PUT0 053.41TRUE00
2028-01-21120PUT0 055.1TRUE00
2028-01-21150PUT0 050.41TRUE00
2028-01-21170PUT0 049.27TRUE00

Latest BCRX Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST62$9.355
Jun 13, 2022 7:59 PM EST55$9.355
Jun 13, 2022 7:59 PM EST25$9.355
Jun 13, 2022 7:59 PM EST10$9.355
Jun 13, 2022 7:59 PM EST1$9.355

BioCryst Pharmaceuticals, Inc (BCRX) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-10SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/882796/000110465920072065/0001104659-20-072065-index.htm
2020-04-27UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/882796/000000000020003589/0000000000-20-003589-index.htm
2019-02-04SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/882796/000021545719003209/0000215457-19-003209-index.htm
2020-02-05SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/882796/000083423720004615/0000834237-20-004615-index.htm
2019-11-19SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/882796/000089914019000618/0000899140-19-000618-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/882796/000089914020000183/0000899140-20-000183-index.htm
2020-04-17SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/882796/000090266420001843/0000902664-20-001843-index.htm
2019-01-11SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/882796/000093041319000073/0000930413-19-000073-index.htm
2019-02-11SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/882796/000093247119004892/0000932471-19-004892-index.htm
2019-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/882796/000110465919008702/0001104659-19-008702-index.htm
2020-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/882796/000110465920018856/0001104659-20-018856-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/882796/000110465920021757/0001104659-20-021757-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/882796/000110465920021905/0001104659-20-021905-index.htm
2020-06-10SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/882796/000110465920072065/0001104659-20-072065-index.htm
2018-12-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760218036067/0001127602-18-036067-index.htm
2018-12-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760218036977/0001127602-18-036977-index.htm
2018-12-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760218037163/0001127602-18-037163-index.htm
2018-12-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760218037166/0001127602-18-037166-index.htm
2018-12-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760218037170/0001127602-18-037170-index.htm
2018-12-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760218037173/0001127602-18-037173-index.htm
2018-12-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760218037177/0001127602-18-037177-index.htm
2018-12-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760218037182/0001127602-18-037182-index.htm
2019-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219000701/0001127602-19-000701-index.htm
2019-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219000710/0001127602-19-000710-index.htm
2019-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219000720/0001127602-19-000720-index.htm
2019-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219000730/0001127602-19-000730-index.htm
2019-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219000736/0001127602-19-000736-index.htm
2019-01-083Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219001579/0001127602-19-001579-index.htm
2019-01-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219001582/0001127602-19-001582-index.htm
2019-01-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219002141/0001127602-19-002141-index.htm
2019-01-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219002367/0001127602-19-002367-index.htm
2019-01-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219002527/0001127602-19-002527-index.htm
2019-01-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219002873/0001127602-19-002873-index.htm
2019-01-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219003053/0001127602-19-003053-index.htm
2019-02-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219003737/0001127602-19-003737-index.htm
2019-03-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219011361/0001127602-19-011361-index.htm
2019-04-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219014988/0001127602-19-014988-index.htm
2019-05-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219017457/0001127602-19-017457-index.htm
2019-05-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219018347/0001127602-19-018347-index.htm
2019-05-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219018740/0001127602-19-018740-index.htm
2019-05-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219019143/0001127602-19-019143-index.htm
2019-05-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219019891/0001127602-19-019891-index.htm
2019-05-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219020298/0001127602-19-020298-index.htm
2019-05-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219020302/0001127602-19-020302-index.htm
2019-05-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219020306/0001127602-19-020306-index.htm
2019-05-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219020310/0001127602-19-020310-index.htm
2019-05-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219020312/0001127602-19-020312-index.htm
2019-05-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219020314/0001127602-19-020314-index.htm
2019-07-033Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219023817/0001127602-19-023817-index.htm
2019-07-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219023901/0001127602-19-023901-index.htm
2019-09-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219027858/0001127602-19-027858-index.htm
2019-09-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219027862/0001127602-19-027862-index.htm
2019-09-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219027867/0001127602-19-027867-index.htm
2019-09-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219027871/0001127602-19-027871-index.htm
2019-09-243Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219029010/0001127602-19-029010-index.htm
2019-09-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219029012/0001127602-19-029012-index.htm
2019-11-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219033001/0001127602-19-033001-index.htm
2019-11-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219033004/0001127602-19-033004-index.htm
2019-11-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219033008/0001127602-19-033008-index.htm
2019-11-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219033017/0001127602-19-033017-index.htm
2019-11-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219033022/0001127602-19-033022-index.htm
2019-11-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219033025/0001127602-19-033025-index.htm
2019-11-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219033029/0001127602-19-033029-index.htm
2019-11-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219033033/0001127602-19-033033-index.htm
2019-11-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219033035/0001127602-19-033035-index.htm
2019-12-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219034162/0001127602-19-034162-index.htm
2019-12-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219034165/0001127602-19-034165-index.htm
2019-12-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219034168/0001127602-19-034168-index.htm
2019-12-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219034170/0001127602-19-034170-index.htm
2019-12-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219035542/0001127602-19-035542-index.htm
2019-12-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219035544/0001127602-19-035544-index.htm
2019-12-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219035547/0001127602-19-035547-index.htm
2019-12-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219035549/0001127602-19-035549-index.htm
2019-12-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219035551/0001127602-19-035551-index.htm
2019-12-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219035553/0001127602-19-035553-index.htm
2019-12-264/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219035849/0001127602-19-035849-index.htm
2019-12-264/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219035852/0001127602-19-035852-index.htm
2020-01-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220001879/0001127602-20-001879-index.htm
2020-01-213Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220001981/0001127602-20-001981-index.htm
2020-02-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220006477/0001127602-20-006477-index.htm
2020-02-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220006488/0001127602-20-006488-index.htm
2020-02-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220006497/0001127602-20-006497-index.htm
2020-02-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220006501/0001127602-20-006501-index.htm
2020-02-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220006505/0001127602-20-006505-index.htm
2020-02-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220006508/0001127602-20-006508-index.htm
2020-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220007615/0001127602-20-007615-index.htm
2020-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220007625/0001127602-20-007625-index.htm
2020-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220007640/0001127602-20-007640-index.htm
2020-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220007672/0001127602-20-007672-index.htm
2020-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220007677/0001127602-20-007677-index.htm
2020-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220007687/0001127602-20-007687-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220009058/0001127602-20-009058-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220009065/0001127602-20-009065-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220009089/0001127602-20-009089-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220009094/0001127602-20-009094-index.htm
2020-03-033Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220009104/0001127602-20-009104-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220009112/0001127602-20-009112-index.htm
2020-04-083Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220013457/0001127602-20-013457-index.htm
2020-05-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220015179/0001127602-20-015179-index.htm
2020-05-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220016548/0001127602-20-016548-index.htm
2020-05-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220016559/0001127602-20-016559-index.htm
2020-05-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220016565/0001127602-20-016565-index.htm
2020-05-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220016569/0001127602-20-016569-index.htm
2020-05-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220016571/0001127602-20-016571-index.htm
2020-05-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220016575/0001127602-20-016575-index.htm
2020-05-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220016580/0001127602-20-016580-index.htm
2020-05-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220016584/0001127602-20-016584-index.htm
2020-05-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220016759/0001127602-20-016759-index.htm
2020-06-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220018704/0001127602-20-018704-index.htm
2020-06-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220018711/0001127602-20-018711-index.htm
2020-06-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220018715/0001127602-20-018715-index.htm
2020-06-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220018719/0001127602-20-018719-index.htm
2020-08-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220023449/0001127602-20-023449-index.htm
2020-09-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220024637/0001127602-20-024637-index.htm
2020-09-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220024642/0001127602-20-024642-index.htm
2020-09-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220024644/0001127602-20-024644-index.htm
2020-09-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220024646/0001127602-20-024646-index.htm
2019-11-12424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/882796/000114036119020338/0001140361-19-020338-index.htm
2019-11-14424B2Prospectus [Rule 424(b)(2)]https://www.sec.gov/Archives/edgar/data/882796/000114036119020642/0001140361-19-020642-index.htm
2019-11-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000114036119020752/0001140361-19-020752-index.htm
2019-11-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000114036119020989/0001140361-19-020989-index.htm
2019-11-21424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/882796/000114036119021082/0001140361-19-021082-index.htm
2019-11-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000114036119021088/0001140361-19-021088-index.htm
2020-04-24S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/882796/000114036120009639/0001140361-20-009639-index.htm
2020-05-04CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/882796/000114036120010641/0001140361-20-010641-index.htm
2020-05-12CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/882796/000114036120011394/0001140361-20-011394-index.htm
2020-05-27424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/882796/000114036120012557/0001140361-20-012557-index.htm
2020-05-29424B2Prospectus [Rule 424(b)(2)]https://www.sec.gov/Archives/edgar/data/882796/000114036120012652/0001140361-20-012652-index.htm
2020-06-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000114036120012787/0001140361-20-012787-index.htm
2020-06-10S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/882796/000114036120013520/0001140361-20-013520-index.htm
2020-06-10S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/882796/000114036120013521/0001140361-20-013521-index.htm
2020-06-10S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/882796/000114036120013522/0001140361-20-013522-index.htm
2019-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/882796/000114420419007217/0001144204-19-007217-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/882796/000114420419008282/0001144204-19-008282-index.htm
2019-01-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184319000006/0001171843-19-000006-index.htm
2019-01-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184319000126/0001171843-19-000126-index.htm
2019-02-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184319000749/0001171843-19-000749-index.htm
2019-02-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184319001171/0001171843-19-001171-index.htm
2019-03-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184319001442/0001171843-19-001442-index.htm
2019-03-1410-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/882796/000117184319001727/0001171843-19-001727-index.htm
2019-04-17DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/882796/000117184319002458/0001171843-19-002458-index.htm
2019-04-17DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/882796/000117184319002459/0001171843-19-002459-index.htm
2019-04-29S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/882796/000117184319002720/0001171843-19-002720-index.htm
2019-05-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184319003094/0001171843-19-003094-index.htm
2019-05-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/882796/000117184319003220/0001171843-19-003220-index.htm
2019-05-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184319003529/0001171843-19-003529-index.htm
2019-06-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184319003812/0001171843-19-003812-index.htm
2019-06-04S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/882796/000117184319003816/0001171843-19-003816-index.htm
2019-06-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184319004220/0001171843-19-004220-index.htm
2019-07-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184319004257/0001171843-19-004257-index.htm
2019-07-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184319004259/0001171843-19-004259-index.htm
2019-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184319005182/0001171843-19-005182-index.htm
2019-08-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/882796/000117184319005326/0001171843-19-005326-index.htm
2019-09-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184319005941/0001171843-19-005941-index.htm
2019-09-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184319006063/0001171843-19-006063-index.htm
2019-09-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184319006137/0001171843-19-006137-index.htm
2019-10-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184319006859/0001171843-19-006859-index.htm
2019-11-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184319007064/0001171843-19-007064-index.htm
2019-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184319007155/0001171843-19-007155-index.htm
2019-11-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184319007214/0001171843-19-007214-index.htm
2019-11-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184319007363/0001171843-19-007363-index.htm
2019-11-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/882796/000117184319007384/0001171843-19-007384-index.htm
2019-12-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184319008053/0001171843-19-008053-index.htm
2020-01-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184320000183/0001171843-20-000183-index.htm
2020-01-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184320000241/0001171843-20-000241-index.htm
2020-02-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184320000650/0001171843-20-000650-index.htm
2020-02-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184320001018/0001171843-20-001018-index.htm
2020-02-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184320001229/0001171843-20-001229-index.htm
2020-03-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184320001491/0001171843-20-001491-index.htm
2020-03-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184320001492/0001171843-20-001492-index.htm
2020-03-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184320001589/0001171843-20-001589-index.htm
2020-03-1310-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/882796/000117184320001710/0001171843-20-001710-index.htm
2020-03-19PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/882796/000117184320001853/0001171843-20-001853-index.htm
2020-03-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184320002124/0001171843-20-002124-index.htm
2020-03-31DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/882796/000117184320002184/0001171843-20-002184-index.htm
2020-03-31DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/882796/000117184320002185/0001171843-20-002185-index.htm
2020-04-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184320002295/0001171843-20-002295-index.htm
2020-04-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184320002530/0001171843-20-002530-index.htm
2020-05-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184320003357/0001171843-20-003357-index.htm
2020-05-1110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/882796/000117184320003557/0001171843-20-003557-index.htm
2020-05-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184320003680/0001171843-20-003680-index.htm
2020-08-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184320005453/0001171843-20-005453-index.htm
2020-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184320005596/0001171843-20-005596-index.htm
2020-08-1010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/882796/000117184320005753/0001171843-20-005753-index.htm
2020-08-12S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/882796/000117184320005862/0001171843-20-005862-index.htm
2020-08-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184320006161/0001171843-20-006161-index.htm
2020-08-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184320006178/0001171843-20-006178-index.htm
2020-09-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184320006249/0001171843-20-006249-index.htm
2020-09-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184320006729/0001171843-20-006729-index.htm
2020-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184320007628/0001171843-20-007628-index.htm
2020-11-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/882796/000117184320007740/0001171843-20-007740-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/882796/000117266120000839/0001172661-20-000839-index.htm
2019-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/882796/000119380519000192/0001193805-19-000192-index.htm
2020-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/882796/000119380520000190/0001193805-20-000190-index.htm
2019-02-11SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/882796/000127417319000036/0001274173-19-000036-index.htm
2020-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/882796/000127417320000008/0001274173-20-000008-index.htm
2019-05-29SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/882796/000131924419000051/0001319244-19-000051-index.htm
2020-01-22SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/882796/000131924420000014/0001319244-20-000014-index.htm
2020-05-14EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/882796/999999999520001159/9999999995-20-001159-index.htm
2018-12-17CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/882796/999999999718009595/9999999997-18-009595-index.htm
2020-05-01CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/882796/999999999720002395/9999999997-20-002395-index.htm

BioCryst Pharmaceuticals, Inc (BCRX) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of BioCryst Pharmaceuticals, Inc (BCRX). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 85%
Institutional Ownership: 7395%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2018-12-10Lynne PowellSenior VP - CCOSell2,000.009.0118,020.000.00https://www.sec.gov/Archives/edgar/data/882796/000112760218036067/0001127602-18-036067-index.htm
2018-12-10Lynne PowellSenior VP - CCOSell2,000.009.1118,220.000.00https://www.sec.gov/Archives/edgar/data/882796/000112760218036067/0001127602-18-036067-index.htm
2019-01-14Lynne PowellSenior VP - CCOSell954.009.208,776.800.00https://www.sec.gov/Archives/edgar/data/882796/000112760219002141/0001127602-19-002141-index.htm
2019-01-16Lynne PowellSenior VP - CCOSell3,046.009.2728,236.420.00https://www.sec.gov/Archives/edgar/data/882796/000112760219002367/0001127602-19-002367-index.htm
2019-01-18Lynne PowellSenior VP - CCOSell2,000.009.4018,800.000.00https://www.sec.gov/Archives/edgar/data/882796/000112760219002527/0001127602-19-002527-index.htm
2019-01-25Lynne PowellSenior VP - CCOSell6,000.009.6057,600.000.00https://www.sec.gov/Archives/edgar/data/882796/000112760219002873/0001127602-19-002873-index.htm
2019-01-28Lynne PowellSenior VP - CCOSell4,000.009.8839,520.000.00https://www.sec.gov/Archives/edgar/data/882796/000112760219002873/0001127602-19-002873-index.htm
2019-01-28Lynne PowellSenior VP - CCOSell2,000.009.9119,820.000.00https://www.sec.gov/Archives/edgar/data/882796/000112760219002873/0001127602-19-002873-index.htm
2020-03-01THERESA HEGGIEDirectorBuy1,666.003.004,998.0010,092.00https://www.sec.gov/Archives/edgar/data/882796/000112760220009089/0001127602-20-009089-index.htm
2019-11-18Alane P BarnesSenior VP, Chief Legal OfficerBuy20,000.001.4529,000.00102,061.00https://www.sec.gov/Archives/edgar/data/882796/000112760219033008/0001127602-19-033008-index.htm
2020-06-01THERESA HEGGIEDirectorBuy1,112.004.504,998.4411,204.00https://www.sec.gov/Archives/edgar/data/882796/000112760220018715/0001127602-20-018715-index.htm
2020-08-31THERESA HEGGIEDirectorBuy1,204.004.154,996.6012,408.00https://www.sec.gov/Archives/edgar/data/882796/000112760220024644/0001127602-20-024644-index.htm
2019-05-17THOMAS R II STAABSenior Vice President and CFOSell2,500.007.4518,625.00125,176.00https://www.sec.gov/Archives/edgar/data/882796/000112760219019143/0001127602-19-019143-index.htm
2019-05-16THOMAS R II STAABSenior Vice President and CFOSell7,250.007.7255,970.00127,676.00https://www.sec.gov/Archives/edgar/data/882796/000112760219019143/0001127602-19-019143-index.htm
2019-01-31Yarlagadda S BabuSenior VP - Drug DiscoveryBuy19,686.001.2023,623.20127,786.00https://www.sec.gov/Archives/edgar/data/882796/000112760219003737/0001127602-19-003737-index.htm
2019-01-28THOMAS R II STAABSenior Vice President and CFOSell5,000.009.8549,250.00128,426.00https://www.sec.gov/Archives/edgar/data/882796/000112760219003053/0001127602-19-003053-index.htm
2019-05-15THOMAS R II STAABSenior Vice President and CFOSell7,250.007.9257,420.00130,176.00https://www.sec.gov/Archives/edgar/data/882796/000112760219018740/0001127602-19-018740-index.htm
2019-01-31Yarlagadda S BabuSenior VP - Drug DiscoveryBuy12,188.001.2014,625.60132,272.00https://www.sec.gov/Archives/edgar/data/882796/000112760219003737/0001127602-19-003737-index.htm
2019-04-04THOMAS R II STAABSenior Vice President and CFOSell7,500.008.8166,075.00132,676.00https://www.sec.gov/Archives/edgar/data/882796/000112760219014988/0001127602-19-014988-index.htm
2019-05-02THOMAS R II STAABSenior Vice President and CFOSell7,750.007.3056,575.00132,676.00https://www.sec.gov/Archives/edgar/data/882796/000112760219017457/0001127602-19-017457-index.htm
2019-05-06THOMAS R II STAABSenior Vice President and CFOSell9,000.007.7569,750.00132,676.00https://www.sec.gov/Archives/edgar/data/882796/000112760219017457/0001127602-19-017457-index.htm
2019-05-09THOMAS R II STAABSenior Vice President and CFOSell9,750.007.6374,392.50132,676.00https://www.sec.gov/Archives/edgar/data/882796/000112760219018347/0001127602-19-018347-index.htm
2019-05-13THOMAS R II STAABSenior Vice President and CFOSell9,750.007.7675,660.00132,676.00https://www.sec.gov/Archives/edgar/data/882796/000112760219018347/0001127602-19-018347-index.htm
2019-05-14THOMAS R II STAABSenior Vice President and CFOSell4,500.007.6234,290.00132,676.00https://www.sec.gov/Archives/edgar/data/882796/000112760219018740/0001127602-19-018740-index.htm
2019-01-28THOMAS R II STAABSenior Vice President and CFOBuy5,000.005.4527,250.00133,426.00https://www.sec.gov/Archives/edgar/data/882796/000112760219003053/0001127602-19-003053-index.htm
2019-05-16THOMAS R II STAABSenior Vice President and CFOBuy4,750.001.426,745.00134,926.00https://www.sec.gov/Archives/edgar/data/882796/000112760219019143/0001127602-19-019143-index.htm
2019-05-14THOMAS R II STAABSenior Vice President and CFOBuy4,500.001.426,390.00137,176.00https://www.sec.gov/Archives/edgar/data/882796/000112760219018740/0001127602-19-018740-index.htm
2019-05-15THOMAS R II STAABSenior Vice President and CFOBuy4,750.001.426,745.00137,426.00https://www.sec.gov/Archives/edgar/data/882796/000112760219018740/0001127602-19-018740-index.htm
2019-04-04THOMAS R II STAABSenior Vice President and CFOBuy7,500.005.5141,325.00140,176.00https://www.sec.gov/Archives/edgar/data/882796/000112760219014988/0001127602-19-014988-index.htm
2019-05-02THOMAS R II STAABSenior Vice President and CFOBuy7,750.005.5142,702.50140,426.00https://www.sec.gov/Archives/edgar/data/882796/000112760219017457/0001127602-19-017457-index.htm
2019-05-06THOMAS R II STAABSenior Vice President and CFOBuy9,000.005.5149,590.00141,676.00https://www.sec.gov/Archives/edgar/data/882796/000112760219017457/0001127602-19-017457-index.htm
2019-05-09THOMAS R II STAABSenior Vice President and CFOBuy9,750.005.5153,722.50142,426.00https://www.sec.gov/Archives/edgar/data/882796/000112760219018347/0001127602-19-018347-index.htm
2019-05-13THOMAS R II STAABSenior Vice President and CFOBuy9,750.005.5153,722.50142,426.00https://www.sec.gov/Archives/edgar/data/882796/000112760219018347/0001127602-19-018347-index.htm
2019-11-18KENNETH B JR LEEDirectorBuy5,000.001.457,250.0015,252.00https://www.sec.gov/Archives/edgar/data/882796/000112760219033029/0001127602-19-033029-index.htm
2019-11-18Yarlagadda S BabuSenior VP - Drug DiscoveryBuy25,000.001.4536,250.00155,587.00https://www.sec.gov/Archives/edgar/data/882796/000112760219033004/0001127602-19-033004-index.htm
2019-09-01THERESA HEGGIEDirectorBuy1,672.002.994,999.281,672.00https://www.sec.gov/Archives/edgar/data/882796/000112760219027871/0001127602-19-027871-index.htm
2018-12-10Lynne PowellSenior VP - CCOBuy2,000.003.226,440.002,000.00https://www.sec.gov/Archives/edgar/data/882796/000112760218036067/0001127602-18-036067-index.htm
2019-01-18Lynne PowellSenior VP - CCOBuy2,000.003.226,440.002,000.00https://www.sec.gov/Archives/edgar/data/882796/000112760219002527/0001127602-19-002527-index.htm
2019-01-28Lynne PowellSenior VP - CCOBuy2,000.003.226,440.002,000.00https://www.sec.gov/Archives/edgar/data/882796/000112760219002873/0001127602-19-002873-index.htm
2019-03-12STEVE ASELAGEDirectorBuy2,000.008.3016,600.002,000.00https://www.sec.gov/Archives/edgar/data/882796/000112760219011361/0001127602-19-011361-index.htm
2019-11-18STEVE ASELAGEDirectorBuy15,000.001.4521,750.0021,672.00https://www.sec.gov/Archives/edgar/data/882796/000112760219033001/0001127602-19-033001-index.htm
2019-12-01STEVE ASELAGEDirectorBuy1,754.002.854,998.9023,426.00https://www.sec.gov/Archives/edgar/data/882796/000112760219034168/0001127602-19-034168-index.htm
2020-03-01STEVE ASELAGEDirectorBuy1,666.003.004,998.0025,092.00https://www.sec.gov/Archives/edgar/data/882796/000112760220009094/0001127602-20-009094-index.htm
2020-06-01STEVE ASELAGEDirectorBuy1,112.004.504,998.4426,204.00https://www.sec.gov/Archives/edgar/data/882796/000112760220018719/0001127602-20-018719-index.htm
2018-12-18William P SheridanSenior VP - CMOSell20,488.007.58155,299.042,725.00https://www.sec.gov/Archives/edgar/data/882796/000112760218036977/0001127602-18-036977-index.htm
2019-09-01ROBERT ALEXANDER INGRAMDirectorBuy6,270.002.9918,747.3028,088.00https://www.sec.gov/Archives/edgar/data/882796/000112760219027858/0001127602-19-027858-index.htm
2020-08-31STEVE ASELAGEDirectorBuy2,409.004.159,997.3528,613.00https://www.sec.gov/Archives/edgar/data/882796/000112760220024642/0001127602-20-024642-index.htm
2019-01-16Lynne PowellSenior VP - CCOBuy3,046.003.229,808.123,046.00https://www.sec.gov/Archives/edgar/data/882796/000112760219002367/0001127602-19-002367-index.htm
2019-01-28Lynne PowellSenior VP - CCOBuy4,000.003.2212,880.004,000.00https://www.sec.gov/Archives/edgar/data/882796/000112760219002873/0001127602-19-002873-index.htm
2019-09-01Nancy J HutsonDirectorBuy3,344.002.999,998.5643,046.00https://www.sec.gov/Archives/edgar/data/882796/000112760219027862/0001127602-19-027862-index.htm
2019-11-18Megan SniecinskiChief Business OfficerBuy45,000.001.4565,250.0045,000.00https://www.sec.gov/Archives/edgar/data/882796/000112760219033033/0001127602-19-033033-index.htm
2019-11-18ROBERT ALEXANDER INGRAMDirectorBuy20,000.001.4529,000.0048,088.00https://www.sec.gov/Archives/edgar/data/882796/000112760219033025/0001127602-19-033025-index.htm
2019-05-22STEVE ASELAGEDirectorBuy3,000.003.5710,710.005,000.00https://www.sec.gov/Archives/edgar/data/882796/000112760219019891/0001127602-19-019891-index.htm
2019-11-18Nancy J HutsonDirectorBuy10,000.001.4514,500.0053,046.00https://www.sec.gov/Archives/edgar/data/882796/000112760219033022/0001127602-19-033022-index.htm
2020-08-11Anthony DoyleChief Financial OfficerBuy54,000.004.08220,320.0054,000.00https://www.sec.gov/Archives/edgar/data/882796/000112760220023449/0001127602-20-023449-index.htm
2019-12-01ROBERT ALEXANDER INGRAMDirectorBuy6,578.002.8518,747.3054,666.00https://www.sec.gov/Archives/edgar/data/882796/000112760219034162/0001127602-19-034162-index.htm
2019-12-01Nancy J HutsonDirectorBuy3,508.002.859,997.8056,554.00https://www.sec.gov/Archives/edgar/data/882796/000112760219034165/0001127602-19-034165-index.htm
2020-03-01Nancy J HutsonDirectorBuy3,333.003.009,999.0059,887.00https://www.sec.gov/Archives/edgar/data/882796/000112760220009065/0001127602-20-009065-index.htm
2019-01-25Lynne PowellSenior VP - CCOBuy6,000.003.2219,320.006,000.00https://www.sec.gov/Archives/edgar/data/882796/000112760219002873/0001127602-19-002873-index.htm
2020-03-01ROBERT ALEXANDER INGRAMDirectorBuy6,250.003.0018,750.0060,916.00https://www.sec.gov/Archives/edgar/data/882796/000112760220009058/0001127602-20-009058-index.htm
2020-06-01Nancy J HutsonDirectorBuy2,224.004.509,996.8862,111.00https://www.sec.gov/Archives/edgar/data/882796/000112760220018711/0001127602-20-018711-index.htm
2020-08-31Nancy J HutsonDirectorBuy1,204.004.154,996.6063,315.00https://www.sec.gov/Archives/edgar/data/882796/000112760220024646/0001127602-20-024646-index.htm
2020-06-01ROBERT ALEXANDER INGRAMDirectorBuy4,171.004.5018,748.6565,087.00https://www.sec.gov/Archives/edgar/data/882796/000112760220018704/0001127602-20-018704-index.htm
2019-09-01STEVE ASELAGEDirectorBuy1,672.002.994,999.286,672.00https://www.sec.gov/Archives/edgar/data/882796/000112760219027867/0001127602-19-027867-index.htm
2019-11-18THERESA HEGGIEDirectorBuy5,000.001.457,250.006,672.00https://www.sec.gov/Archives/edgar/data/882796/000112760219033017/0001127602-19-033017-index.htm
2020-08-31ROBERT ALEXANDER INGRAMDirectorBuy4,518.004.1518,749.7069,605.00https://www.sec.gov/Archives/edgar/data/882796/000112760220024637/0001127602-20-024637-index.htm
2019-11-18Jon P StonehousePresident & CEOBuy50,000.001.4572,500.00778,086.00https://www.sec.gov/Archives/edgar/data/882796/000112760219033035/0001127602-19-033035-index.htm
2019-12-01THERESA HEGGIEDirectorBuy1,754.002.854,998.908,426.00https://www.sec.gov/Archives/edgar/data/882796/000112760219034170/0001127602-19-034170-index.htm
2019-01-14Lynne PowellSenior VP - CCOBuy954.003.223,071.88954.00https://www.sec.gov/Archives/edgar/data/882796/000112760219002141/0001127602-19-002141-index.htm